DERM - Journey Medical GAAP EPS of -$0.21 misses by $0.02 revenue of $79.18M beats by $0.21M
2024-03-21 16:04:13 ET
More on Journey Medical
- Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment
- Journey Medical submits NDA for DFD-29 for rosacea
- Seeking Alpha’s Quant Rating on Journey Medical
- Historical earnings data for Journey Medical
- Financial information for Journey Medical